Phase I trial of gemcitabine (GEM) and cisplatin (CP) for non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Shepherd, F [1 ]
Cormier, Y [1 ]
Burges, R [1 ]
Crump, M [1 ]
Strack, T [1 ]
机构：
[1] UNIV TORONTO,TORONTO,ON,CANADA
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1080 / 1080
页数：1
相关论文
共 50 条
  • [1] Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study
    Steward, WP
    Dunlop, DJ
    Cameron, C
    Talbot, DC
    Kleisbauer, JL
    Thomas, P
    Guerin, JC
    Perol, M
    Sanson, C
    Dabouis, G
    Lacroix, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1081 - 1081
  • [2] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
  • [3] Phase I study of gemcitabine (GEM) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC).
    Kawabata, S
    Oka, M
    Fukuda, M
    Kinoshita, A
    Fukuda, M
    Nagashima, S
    Nakamura, Y
    Nakano, H
    Soda, H
    Kohno, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 688S - 688S
  • [4] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [5] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [6] Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: A preliminary report
    Shepherd, FA
    Burkes, R
    Cormier, Y
    Crump, M
    Feld, R
    Strack, T
    LUNG CANCER, 1996, 14 (01) : 135 - 144
  • [7] Gemcitabine (GEM) plus vinorelbine (NVB) in non-small cell lung cancer (NSCLC)
    Michetti, G
    Beretta, GD
    Belometti, MO
    Gritti, G
    Marini, B
    Agazzi, A
    Labianca, R
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 92
  • [8] Phase I II trial with cisplatin and increasing doses of gemcitabine in stage IV non-small cell lung cancer (NSCLC) diseminado.
    Martínez, J
    Artal, A
    Alonso, V
    Herrero, A
    Maurel, J
    Zorrilla, M
    Puértolas, T
    Ceballos, C
    Antón, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S67 - S67
  • [9] Phase I study of low-dose cisplatin (CDDP) and gemcitabine (GEM) chemotherapy for elderly patients with advanced non-small cell lung cancer (NSCLC)
    Buffoni, L.
    Dongiovanni, D.
    Barone, C.
    Fissore, C.
    Larovere, E.
    Grillo, R.
    Salvadori, A.
    Birocco, N.
    Ciuffreda, L.
    Bertetto, O.
    Schena, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI21 - XI22
  • [10] Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
    Crino, L
    Seagliotti, G
    Marangolo, M
    Figoli, F
    Clerici, M
    DeMarinis, F
    Salvati, F
    Cruciani, G
    Dogliotti, L
    Cocconi, G
    Paccagnella, A
    Adamo, V
    Incoronato, P
    Scarcella, L
    Mosconi, AM
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1064 - 1064
12345